Home | Sitemap | Search | Contact A- A A+
   
 
    Public Member Support us  
 

IBCSG 26-02 / BIG 4-02 (PERCHE) 

A phase III trial evaluating the role of chemotherapy as adjuvant therapy for premenopausal women with endocrine responsive breast cancer who receive endocrine therapy

Premenopausal Endocrine Responsive Chemotherapy Trial (PERCHE)

DESIGN

please click on the picture to see a larger version

Results & Publications


Posters


Presentations

Study Chairs
BIG: Dr. Rosalba Torrisi - Milano, Italy
US Intergroup: Dr. Edith A. Perez - Jacksonville, USA

Statistician
Dr. Meredith Regan

Trial Coordinators
Holly Shaw, Vanessa Palermo

Data Managers
Karolyn Scott, Jocelyn Swick, Monica Greco, Adriana Mora de Karausch, Adrianna Cesario, Amy Dickinson, Monique Fortunato, Kimberly Lupejkis, Vanessa Palermo, Patricia Gonzales

IBCSG Data Management Center/FSTRF
4033 Maple Road
Amherst, New York 14226 USA
Phone: +1 716 834 0900
Fax: +1 716 836 6097
Email: ibcsg24-26_STP@fstrf.org

Date of Activation
August 4, 2003

Date of Closure
December 31, 2006

Targeted Accrual
1750 patients

Final Accrual
29 patients


Results Publications Results & Publications
Other Pathology


News

01.10.2014:
Benefiz-Gala mit Anton Mosimann Mittwoch 1. Oktober 2014 18.30 Uhr AURA, Bleicherweg 5, 8001 Zürich

11.09.2014:
The next IBCSG Annual Meeting will take place in Vienna, Austria on March 21st and 22nd, 2015 in

11.09.2014:
Breast Cancer Conference BCC 2015 18 - 21 March 2015 / Vienna / Austria  

All News

 
  Print